HeartStart Defibrillator/Monitor

HeartStart XL

Defibrillator/Monitor

Trouver des produits similaires

With manual and AED capabilities for ALS and BLS clinicians, Philips HeartStart XL defibrillator/monitor is designed to meet a wide variety of defibrillation and monitoring needs. All that in one lightweight, easy-to-use device.

Caractéristiques
Easy transport for fast response

Easy transport for fast response

At just under 14 lbs., the HeartStart XL easily fits on a hospital stretcher for transport through the hospital to where cardiac care is needed. It charges to the highest energy level, 200 Joules, in less than 3.5 seconds. Its rugged to withstand the rigors of hospital use and patient transport.
Choices of modes for all levels of users

Choices of modes for all levels of users

HeartStart XL offers both manual and automated external defibrillator (AED) capabilities. This enables the first caregiver on the scene, whether an ALS or BLS clinician, to deliver potentially lifesaving defibrillation therapy.
AED mode provides extra guidance

AED mode provides extra guidance

In AED mode, voice prompts and text messages guide BLS users through the defibrillation process, while the HeartStart XL continuously monitors and displays the patient's ECG.
Manual mode

Manual mode

Upon the arrival of ALS personnel, HeartStart XL is easily switched from AED to manual mode. It allows operators to access the unit's advanced therapeutic features such as selectable energy (from 2 to 200 Joules), non-invasive pacing (optional), SpO2 (optional), and synchronized cardioversion.
SMART Biphasic technology is today's standard of care

SMART Biphasic technology is today's standard of care

Philips pioneered biphasic therapy in external defibrillators and today biphasic is the standard of care. Philips biphasic therapy is clinically proven to deliver high first shock efficacy for long downtime sudden cardiac arrest (SCA) patients, and effectively defibrillate across the full spectrum of patients.
Real-time impedance compensation personalizes therapy

Real-time impedance compensation personalizes therapy

Philips success across a broad patient population is due in part to its real-time impedance compensation technology, which automatically measures the patient’s chest impedance and optimizes the waveform for every shock. Patients receive personalized therapy for the best chance of a positive outcome.¹⁻¹⁶
Synchronized cardioversion has been clinically validated

Synchronized cardioversion has been clinically validated

Philips SMART Biphasic waveform has undergone clinical testing, demonstrating its effectiveness for cardioversion of atrial fibrillation. 15,16,17
1-2-3 operation to save time

1-2-3 operation to save time

True 1-2-3 operation makes defibrillation intuitive for all users. In the AED mode, Voice and text prompts guide users through the defibrillation process. It is pre-set at 150 Joules non-escalating energy level.
Multi-function accessories for adults and children

Multi-function accessories for adults and children

The system is equipped with adult and pediatric pads for defibrillation, ECG monitoring, pacing, and synchronized cardioversion. Optional anterior/anterior adult paddles convert to pediatric by removing the outer contacts.
Sterilizable internal paddles for use in sterile areas

Sterilizable internal paddles for use in sterile areas

Switch and switchless internal paddles are designed for open-chest defibrillation in the operating room.
  • 1 Page RL, Joglar JA, Kowal RC, et al Use of automated external defibrillators by a U.S. airline. New England Journal of Medicine. 2000;343:1210-1216.
  • 2 Capucci A, Aschieri D, Piepoli MF, et al. Tripling survival from sudden cardiac arrest via early defibrillation without traditional education in cardiopulmonary resuscitation. Circulation. 2002;106:1065-1070.
  • 3 White RD, Atkinson EJ. Patient outcomes following defibrillation with a low energy biphasic truncated exponential waveform in out-of-hospital cardiac arrest. Resuscitation. 2001;49:9-14.
  • 4 Gliner BE, Jorgenson DB, Poole JE, et al. Treatment of out-of-hospital cardiac arrest with a low-energy impedance-compensating biphasic waveform automatic external defibrillation. Biomedical Instrumentation & Technology. 1998;32:631-644.
  • 5 White RD, Russell JK. Refibrillation, resuscitation and survival in out-of-hospital sudden cardiac arrest victims treated with biphasic automated external defibrillators. Resuscitation. 2002; 55(1):17-23.
  • 6 Gliner BE, White RD. Electrocardiographic evaluation of defibrillation shocks delivered to out-of-hospital sudden cardiac arrest patients. Resuscitation. 1999;41(2):133- 144.
  • 7 Poole JE, White RD, Kanz KG, et al. Low-energy impedance-compensating biphasic waveforms terminate ventricular fibrillation at high rates in victims of out-of-hospital cardiac arrest. Journal of Cardiovascular Electrophysiology. 1997;8:1373-1385.
  • 8 Caffrey SL, Willoughby PJ, Pepe PF, et al. Public use of automated external defibrillators. New England Journal of Medicine. 2002;347:1242-1247.
  • 9 Gurnett CA, Atkins DL. Successful use of a biphasic waveform automated external defibrillator in a high-risk child. American Journal of Cardiology. 2000;86:1051- 1053.
  • 10 Martens PR, Russell JK, Wolcke B, et al. Optimal response to cardiac arrest study: defibrillation waveform effects. Resuscitation. 2001;49:233-243.
  • 11 White RD, Blackwell TH, Russell JK, Jorgenson DB. Body weight does not affect defibrillation, resuscitation or survival in patients with out-of-hospital biphasic waveform defibrillator. Critical Care Medicine. 2004; 32(9) Supplement: S387-S392.
  • 12 White RD, Blackwell TH, Russell JK, Snyder DE, Jorgenson DB. Transthoracic impedance does not affect defibrillation, resuscitation or survival in patients with out-of-hospital cardiac arrest treated with a non-escalating biphasic waveform defibrillator. Resuscitation. 2005 Jan; 64(1):63-69.
  • 13 Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Circulation. 2000;102:1780-7
  • 14 Hess EP, Russell JK, Liu PY, et al. A high peak current 150-J fixed-energy defibrillation protocol treats recurrent ventricular fibrillation (VF) as effectively as initial VF. Resuscitation. 2008 Oct;79(1):28- 33.
  • 15 Santomauro M, Borrelli A, Ottaviano L, et al. Transthoracic cardioversion in patients with atrial fibrillation: comparison of three different waveforms. Ital Heart J. Suppl. 2004 Jan; 5(1 Suppl):36-43.
  • 16 Page RL, Kerber RE, Russell JK, et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation. The results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol. 2002;39:1956-1963.
  • 17 Benditt, DG et al. "Biphasic Waveform Cardioversion as an Alternative to Internal Cardioversion for Atrial Fibrillation Refractory to Conventional Monophasic Waveform Transthoracic Shock." Am J Cardiol, December 15, 2001;88(12):1426-1428.

Pour toute demande d’assistance technique, merci de contacter le N° 0810 835 624.

Êtes-vous un professionnel de santé ?
Veuillez cocher la case

Remarque :

Les informations présentes sur ce site Internet sont destinées à des professionnels de santé.